Aro Biotherapeutics Secures $41.5M Series B Financing - ARO Live

Philadelphia, PA, November 28, 2023 --- Aro Biotherapeutics, a clinical stage biotechnology company pioneering the development of tissue-targeted genetic medicines, today announced …

CouponFollow Extension

$41
OFF

Aro Biotherapeutics Secures $41.5M Series B Financing - ARO Live

3 weeks from now

Philadelphia, PA, November 28, 2023 --- Aro Biotherapeutics, a clinical stage biotechnology company pioneering the development of tissue-targeted genetic medicines, today announced …

arobiotx.com

$41
OFF

Aro Biotherapeutics Secures $41.5M Series B Financing

3 weeks from now

Nov 28, 2023 · Aro Biotherapeutics Secures $41.5M Series B Financing - Funds will support progression of Aro’s pipeline of Centyrin-siRNA programs, including ABX1100, a novel …

businesswire.com

$41
OFF

Aro Biotherapeutics Secures $41.5M Series B Financing

3 weeks from now

Nov 28, 2023 · PHILADELPHIA--(BUSINESS WIRE)-- Aro Biotherapeutics, a clinical stage biotechnology company pioneering the development of tissue-targeted genetic medicines, …

biospace.com

$41
OFF

Aro Biotherapeutics Raises $41.5M Series B Financing

3 weeks from now

Nov 28, 2023 · Aro Biotherapeutics, a Philadelphia, PA-based clinical stage biotechnology company, raised $41.5M in Series B funding.. The round was led by Cowen Healthcare …

finsmes.com

$41
OFF

Aro Biotherapeutics Secures $41.5M Series B Financing - Yahoo …

3 weeks from now

PHILADELPHIA, November 28, 2023--Aro Biotherapeutics, a clinical stage biotechnology company pioneering the development of tissue-targeted genetic medicines, today announced …

yahoo.com

$41
OFF

Breaking Boundaries: Aro Biotherapeutics Secures $41.5 Million In ...

3 weeks from now

Aro Biotherapeutics, a trailblazer in the biotechnology sector based in Philadelphia, is excited to announce a significant funding milestone, having raised $41,500,000 to propel its innovative …

leadsontrees.com

$41
OFF

Aro Biotherapeutics Secures $41.5M Series B Financing

3 weeks from now

Dec 2, 2023 · PHILADELPHIA–(BUSINESS WIRE)–Aro Biotherapeutics, a clinical stage biotechnology company pioneering the development of tissue-targeted genetic medicines, …

impactnews-wire.com

$41
OFF

Aro Biotherapeutics Secures $41.5M Series B Financing

3 weeks from now

Nov 28, 2023 · Aro recently announced the start of a first-in-human with ABX1100, and the Company anticipates that initial data from this study will be presented in 2024. In addition, the …

observer-reporter.com

$41
OFF

Aro Biotherapeutics Secures $41.5M Series B Financing

3 weeks from now

Nov 30, 2023 · Aro recently announced the start of a first-in-human with ABX1100, and the Company anticipates that initial data from this study will be presented in 2024. In addition, the …

pharmajournalist.com

$41
OFF

Aro Biotherapeutics Secures $41.5M Series B Financing

3 weeks from now

Nov 28, 2023 · PHILADELPHIA--(BUSINESS WIRE)--Aro Biotherapeutics, a clinical stage biotechnology company pioneering the development of tissue-targeted genetic medicines, …

lifesciencespa.org

$41
OFF

Aro Biotherapeutics Inks $41.5M Series B - Vcnewsdaily.com

3 weeks from now

PHILADELPHIA, PA, Aro Biotherapeutics, a clinical stage biotechnology company pioneering the development of tissue-targeted genetic medicines, has secured $41.5 million in a Series B …

vcnewsdaily.com

$41
OFF

Aro Biotherapeutics Secures $41.5M In Series B Funding To …

3 weeks from now

Aro Biotherapeutics raised $41.5M in a Series B funding round led by Cowen Healthcare Investments. Funding participants include Johnson & Johnson Innovation – JJDC, Inc., …

sliceofhealthcare.com

$41
OFF

Aro Biotherapeutics On LinkedIn: Aro Biotherapeutics Secures …

3 weeks from now

We are excited to announce we have secured our Series B financing! https://lnkd.in/d_znquZc | 15 comments on LinkedIn Aro Biotherapeutics on LinkedIn: Aro Biotherapeutics Secures $41.5M …

linkedin.com

$41
OFF

Aro Biotherapeutics Secures $41.5M Series B Financing

3 weeks from now

Philadelphia, PA, November 28, 2023 — Aro Biotherapeutics, a clinical stage biotechnology company pioneering the development of tissue-targeted genetic medicines, today announced …

healthcap.eu

$41
OFF

Aro Biotherapeutics Secures $41.5M Series B Financing

3 weeks from now

Nov 29, 2023 · Aro Biotherapeutics Secures $41.5M Series B Financing. Fintech Investments News. Aro Biotherapeutics Secures $41.5M Series B Financing. by Business Wire November …

globalfintechseries.com

FAQs about Aro Biotherapeutics Secures $41.5M Series B Financing - ARO Live Coupon?

Who is Aro Biotherapeutics?

PHILADELPHIA-- ( BUSINESS WIRE )--Aro Biotherapeutics, a clinical stage biotechnology company pioneering the development of tissue-targeted genetic medicines, today announced it has secured $41.5M in a Series B funding round. ...

What is Aro Biotherapeutics' $88 million Series A financing?

Aro Biotherapeutics announces $88 million Series A financing to advance development of Centyrin-Targeted Genetic Medicines. ...

Why is Aro funding abx1100?

This funding enables us to continue to pursue our mission and bring new medicines to patients who desperately need more effective treatments.” Aro will use the funds to advance development of its lead program, ABX1100, a novel potential treatment for patients with Pompe Disease. ...

What is Aro abx1100?

Aro will use the funds to advance development of its lead program, ABX1100, a novel potential treatment for patients with Pompe Disease. Aro recently announced the start of a first-in-human with ABX1100, and the Company anticipates that initial data from this study will be presented in 2024. ...

Who has joined Aro's Board of directors?

In conjunction with the financing, Christopher Picariello, President, JJDC, has joined Aro’s Board of Directors. “ We are appreciative of the support provided by this syndicate of leading life science industry investors,” said Susan Dillon, Ph.D., Chief Executive Officer of Aro. ...